Tech Company Financing Transactions
NephroGenex Funding Round
Care Capital and private investors joined a $3.3 million Series A capital raise for NephroGenex. The round was announced by the company on 7/6/2007.
Transaction Overview
Company Name
Announced On
7/6/2007
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3200 Beechleaf Ct. 900
Raleigh, NC 27604
USA
Raleigh, NC 27604
USA
Phone
Website
Email Address
Overview
NephroGenex (NASDAQ: NRX) is a biotechnology company applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Isdale
Browse more venture capital transactions:
Prev: 7/5/2007: TheraVida venture capital transaction
Next: 7/6/2007: Reata Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs